BioCardia, Inc. Shareholders' Equity
BioCardia, Inc. (BCDA) had Shareholders' Equity of $2.70 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent $2.70M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$1.07M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $895.00K.
- 2025-09-30: Stockholders' Equity Attributable to Parent $2.63M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $2.70M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | -$1.07M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $895.00K 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $2.63M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$1.89M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | -$1.52M 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $837.00K 10-Q · filed 2026-08-12 | |
| 2024-09-30 | $2.75M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$1.96M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | -$2.27M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | -$1.60M 10-K · filed 2026-03-24 | |
| 2023-09-30 | -$660.00K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $1.64M 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $1.90M 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $4.89M 10-K · filed 2025-03-26 | |
| 2022-09-30 | $4.10M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $6.73M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $7.37M 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $10.38M 10-K · filed 2024-03-27 | |
| 2021-09-30 | $13.41M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $15.67M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $18.56M 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $19.18M 10-K · filed 2023-03-29 | |
| 2020-09-30 | $4.11M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $7.29M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | -$1.28M 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $2.37M 10-K · filed 2022-03-29 | |
| 2019-09-30 | $5.19M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | -$2.24M 10-Q · filed 2020-11-10 | |
| 2019-03-31 | $818.00K 10-Q · filed 2020-11-10 | |
| 2018-12-31 | $3.79M 10-K · filed 2021-03-30 | |
| 2018-09-30 | $2.94M 10-Q · filed 2019-11-19 | |
| 2018-06-30 | $5.76M 10-Q · filed 2019-11-19 | |
| 2018-03-31 | $8.21M 10-Q · filed 2019-11-19 | |
| 2017-12-31 | $11.13M 10-K · filed 2020-04-09 | |
| 2017-09-30 | $13.79M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $16.08M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $18.35M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $20.58M 10-K · filed 2020-04-09 | |
| 2016-09-30 | $19.15M 10-Q · filed 2016-10-17 | |
| 2016-06-30 | $14.02M 10-Q · filed 2016-08-02 | |
| 2016-03-31 | $13.95M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | -$3.44M 10-K · filed 2019-04-02 | $13.87M 10-K · filed 2016-03-25 |
| 2015-09-30 | $13.78M 10-Q · filed 2015-10-29 | |
| 2015-06-30 | $13.69M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $13.62M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | -$43.12M 10-K · filed 2018-03-16 | $13.54M 10-K · filed 2015-03-24 |
| 2014-09-30 | $13.48M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $13.44M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $13.37M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $13.31M 10-K · filed 2016-03-25 | |
| 2013-09-30 | $13.30M 10-Q · filed 2013-11-01 | |
| 2013-06-30 | $13.27M 10-Q · filed 2013-07-26 | |
| 2013-03-31 | $13.27M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $13.29M 10-K · filed 2016-03-25 | |
| 2012-09-30 | $13.25M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $12.80M 10-Q · filed 2012-08-10 | |
| 2012-03-31 | $12.93M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $12.98M 10-K · filed 2014-03-24 | |
| 2011-09-30 | $13.26M 10-Q · filed 2011-11-15 | |
| 2011-06-30 | $13.82M 10-Q/A · filed 2011-11-17 | $14.38M 10-Q · filed 2011-08-11 |
| 2010-12-31 | $3.28M 10-K · filed 2013-03-22 | |
| 2009-12-31 | $14.74M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |